Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.

Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

Individuals with vs without knee, hip, or hand OA were associated with a significantly increased risk for sleep apnea.

The FDA has approved Zegfrovy (sunvozertinib) for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.

RFK Jr praised a meal service “without additives" for people on Medicaid and Medicare, but experts say that the meals are highly processed.

The National Institutes of Health announced plans to limit publisher fees for publicly funded research by Fiscal Year 2026.

Dr Susan Monarez's nomination to director of the CDC will move forward following a positive Senate committee vote.

There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

The likelihood of antiviral prescribing and dispensing among patients with influenza varied by care setting, patient age, and underlying medical conditions.

Individuals with cystic fibrosis or CFTR gene variants have a 3-fold higher risk of developing pancreatic cancer after 50 years of age.

The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.